BCAL DIAGNOSTICS LIMITED - Announcements

Market Cap $23.71M Add to my watchlist

Healthcare Biotechnology

BCAL Diagnostics Limited is an Australia-based biotechnology company, which is focused on... BCAL Diagnostics Limited is an Australia-based biotechnology company, which is focused on improving health outcomes for women. The Company’s principal activities include the development of a novel blood screening test to improve the early diagnosis and monitoring of breast cancer, including preparation for clinical trials. It developed a blood screening test to be used alongside breast cancer screening methods. The technology initially complements imaging technologies, such as the mammogram, while it further progresses the development of a monitoring and screening test suitable for women of all ages and backgrounds in any location. Its BCAL test is a lipid biomarker blood (Breast Cancer Associated Lipids test) test with the potential to be used for breast cancer prevention, screening, and monitoring. The Company has partnered with Precion Inc. to optimize protocols and procedures for the clinical studies required for regulatory approvals across several jurisdictions.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

BDX	Company Presentation - Investor Insights		02/05/24	1.37MB	Share
BDX	Change in substantial holding		01/05/24	233.76KB	Share
BDX	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	26/04/24	521.59KB	Share
BDX	Initial Director's Interest Notice		03/04/24	102.35KB	Share
BDX	Ceasing to be a substantial holder		03/04/24	148.27KB	Share
BDX	Trademark Registrations Received Ahead of Commercial Launch		02/04/24	215.81KB	Share
BDX	Change in substantial holding		27/03/24	225.57KB	Share
BDX	Corporate Presentation		06/03/24	3.52MB	Share
BDX	Appointment of Strategic CEO to Lead Commercial Launch	PRICE SENSITIVE	06/03/24	217.93KB	Share
BDX	Initial Director's Interest Notice		04/03/24	100.22KB	Share
BDX	Final Director's Interest Notice		04/03/24	113.95KB	Share
BDX	BCAL to Host Investor Webcast		01/03/24	180KB	Share
BDX	BCAL Strengthens Board with Appointment of Commercial NED		29/02/24	208.35KB	Share
BDX	Cleansing Notice		28/02/24	191.17KB	Share
BDX	Application for quotation of securities - BDX		28/02/24	16.36KB	Share
BDX	Change in substantial holding		27/02/24	239.41KB	Share
BDX	Half Yearly Report and Accounts	PRICE SENSITIVE	20/02/24	668.63KB	Share
BDX	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/01/24	521.5KB	Share
BDX	Collaboration with KIMS & Indo-American Hospitals Hyderabad		29/11/23	154.96KB	Share
BDX	Director Change of Interest Notices X 4		28/11/23	288.87KB	Share
BDX	Change in substantial holding		28/11/23	254.72KB	Share
BDX	Cleansing Notice		27/11/23	190.16KB	Share
BDX	Application for quotation of securities - BDX		27/11/23	27.23KB	Share
BDX	Application for quotation of securities - BDX		27/11/23	24.62KB	Share
BDX	Application for quotation of securities - BDX		24/11/23	24.77KB	Share
BDX	Results of Meeting		22/11/23	266.35KB	Share
BDX	Annual General Meeting Presentation		22/11/23	3.44MB	Share
BDX	BCAL Receives Research and Development Tax Offset $3m		14/11/23	167.73KB	Share
BDX	BCAL Files Further Foundational Patent Application		06/11/23	166.94KB	Share
BDX	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/10/23	376.8KB	Share
BDX	Letter to Shareholders re Annual General Meeting Notice		20/10/23	201.99KB	Share
BDX	Notice of Annual General Meeting/Proxy Form		20/10/23	783.67KB	Share
BDX	Notification regarding unquoted securities - BDX		17/10/23	29.51KB	Share
BDX	Cleansing Notice		17/10/23	189.53KB	Share
BDX	Application for quotation of securities - BDX		17/10/23	25.31KB	Share
BDX	AGM Date and Closing Date for Director Nominations		04/10/23	167.27KB	Share
BDX	Annual Report to shareholders		29/09/23	2.55MB	Share
BDX	Appendix 4G & Corporate Governance Statement		29/09/23	696.35KB	Share
BDX	Directors Change of Interest Notice X 5		22/09/23	340.12KB	Share
BDX	Cleansing Notice		19/09/23	190.43KB	Share
BDX	Application for quotation of securities - BDX		18/09/23	27.23KB	Share
BDX	Application for quotation of securities - BDX		18/09/23	24.75KB	Share
BDX	BCAL Share Purchase Plan Closes		18/09/23	169.14KB	Share
BDX	BCAL Locks Down Crucial Breast Cancer Signature		11/09/23	169.4KB	Share
BDX	Change in substantial holding		05/09/23	255KB	Share
BDX	Shane Ryan Appointed Chief Operating Officer		05/09/23	163.94KB	Share
BDX	Cleansing Notice		01/09/23	189.56KB	Share
BDX	Application for quotation of securities - BDX		01/09/23	24.83KB	Share
BDX	Preliminary Final Report	PRICE SENSITIVE	30/08/23	505.25KB	Share
BDX	Share Purchase Plan Offer Booklet	PRICE SENSITIVE	30/08/23	352.6KB	Share
BDX	Proposed issue of securities - BDX		29/08/23	38.21KB	Share
BDX	$2.4m Capital Raise to Further BREASTEST Commercialisation	PRICE SENSITIVE	28/08/23	169.6KB	Share
BDX	BCAL Presentation August 2023		24/08/23	4.09MB	Share
BDX	Trading Halt	PRICE SENSITIVE	24/08/23	254.54KB	Share
BDX	Application for quotation of securities - BDX		11/08/23	24.85KB	Share
BDX	Notification of cessation of securities - BDX		11/08/23	21.71KB	Share
BDX	Application for quotation of securities - BDX		10/08/23	24.87KB	Share
BDX	BCAL Investor Education Update & Webinar		08/08/23	3.61MB	Share
BDX	Breakthrough Results a Major Step Towards Commercialisation	PRICE SENSITIVE	02/08/23	193.16KB	Share
BDX	Application for quotation of securities - BDX		28/07/23	26.23KB	Share
BDX	Shares and Options Released from Escrow		28/07/23	107.71KB	Share
BDX	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	27/07/23	387.47KB	Share
BDX	Shareholder Newsletter		20/07/23	915.58KB	Share
BDX	Notification regarding unquoted securities - BDX		30/06/23	28.08KB	Share
BDX	Proposed issue of securities - BDX		30/06/23	25.57KB	Share
BDX	BCAL Findings Presented at ASCO Annual Meeting		06/06/23	165.54KB	Share
BDX	BCAL Appoints David Darling as Advisor		16/05/23	139.49KB	Share
BDX	Notification regarding unquoted securities - BDX		11/05/23	24.59KB	Share
BDX	Change of Director's Interest Notice		03/05/23	75.41KB	Share
BDX	BCAL Opens Development & Clinical Service Laboratory		03/05/23	79.72KB	Share
BDX	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	24/04/23	219.05KB	Share
BDX	Half Yearly Report and Accounts	PRICE SENSITIVE	23/02/23	557.69KB	Share
BDX	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	16/01/23	116.54KB	Share
BDX	Results of Meeting		01/12/22	175.13KB	Share
BDX	Results of Meeting		29/11/22	174.17KB	Share
BDX	BCAL AGM Presentation		29/11/22	1.94MB	Share
BDX	Shareholder Newsletter		16/11/22	2.67MB	Share
BDX	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/10/22	135.99KB	Share
BDX	Letter to Shareholders on Annual General Meeting Notice		28/10/22	177.75KB	Share
BDX	Notice of Annual General Meeting/Proxy Form		28/10/22	723.77KB	Share
BDX	Establishment of Development & Clinical Service Laboratory		25/10/22	45.09KB	Share
BDX	Appendix 4G and Corporate Governance Statement		29/09/22	272.35KB	Share
BDX	Annual Report to shareholders		29/09/22	1.22MB	Share
BDX	Preliminary Final Report	PRICE SENSITIVE	30/08/22	380.59KB	Share
BDX	Application for quotation of securities - BDX		29/08/22	24.76KB	Share
BDX	Proposed issue of securities - BDX		25/08/22	24.73KB	Share
BDX	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/07/22	111.26KB	Share
BDX	Change of Director's Interest Notice		04/07/22	78.84KB	Share
BDX	BCAL Enters US Product Development Agreement with Precion	PRICE SENSITIVE	28/06/22	50.05KB	Share
BDX	Change in substantial holding		27/06/22	257.77KB	Share
BDX	BCAL Presentation Accepted for 2022 ASCO Annual Meeting		01/06/22	38.53KB	Share
BDX	Application for quotation of securities - BDX		03/05/22	24.88KB	Share
BDX	BCAL to Present at NWR Virtual Investor Conference		02/05/22	37.7KB	Share
BDX	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/04/22	189.47KB	Share
BDX	Shareholder Newsletter		24/03/22	326.25KB	Share
BDX	Change of Director's Interest Notice		02/03/22	75.45KB	Share
BDX	Appendix 4D & Interim Report	PRICE SENSITIVE	18/02/22	830.8KB	Share
BDX	Shares to be released from escrow		14/02/22	45.35KB	Share
BDX	7 February Announcement - Additional Information	PRICE SENSITIVE	08/02/22	103.11KB	Share
BDX	Recent Analysis Significantly Improves Commercial Prospects	PRICE SENSITIVE	07/02/22	48.81KB	Share

BDX Company Presentation - Investor Insights
02/05/24		1.37MB	Share
BDX Change in substantial holding
01/05/24		233.76KB	Share
BDX Quarterly Activities/Appendix 4C Cash Flow Report
26/04/24	PRICE SENSITIVE	521.59KB	Share
BDX Initial Director's Interest Notice
03/04/24		102.35KB	Share
BDX Ceasing to be a substantial holder
03/04/24		148.27KB	Share
BDX Trademark Registrations Received Ahead of Commercial Launch
02/04/24		215.81KB	Share
BDX Change in substantial holding
27/03/24		225.57KB	Share
BDX Corporate Presentation
06/03/24		3.52MB	Share
BDX Appointment of Strategic CEO to Lead Commercial Launch
06/03/24	PRICE SENSITIVE	217.93KB	Share
BDX Initial Director's Interest Notice
04/03/24		100.22KB	Share
BDX Final Director's Interest Notice
04/03/24		113.95KB	Share
BDX BCAL to Host Investor Webcast
01/03/24		180KB	Share
BDX BCAL Strengthens Board with Appointment of Commercial NED
29/02/24		208.35KB	Share
BDX Cleansing Notice
28/02/24		191.17KB	Share
BDX Application for quotation of securities - BDX
28/02/24		16.36KB	Share
BDX Change in substantial holding
27/02/24		239.41KB	Share
BDX Half Yearly Report and Accounts
20/02/24	PRICE SENSITIVE	668.63KB	Share
BDX Quarterly Activities/Appendix 4C Cash Flow Report
30/01/24	PRICE SENSITIVE	521.5KB	Share
BDX Collaboration with KIMS & Indo-American Hospitals Hyderabad
29/11/23		154.96KB	Share
BDX Director Change of Interest Notices X 4
28/11/23		288.87KB	Share
BDX Change in substantial holding
28/11/23		254.72KB	Share
BDX Cleansing Notice
27/11/23		190.16KB	Share
BDX Application for quotation of securities - BDX
27/11/23		27.23KB	Share
BDX Application for quotation of securities - BDX
27/11/23		24.62KB	Share
BDX Application for quotation of securities - BDX
24/11/23		24.77KB	Share
BDX Results of Meeting
22/11/23		266.35KB	Share
BDX Annual General Meeting Presentation
22/11/23		3.44MB	Share
BDX BCAL Receives Research and Development Tax Offset $3m
14/11/23		167.73KB	Share
BDX BCAL Files Further Foundational Patent Application
06/11/23		166.94KB	Share
BDX Quarterly Activities/Appendix 4C Cash Flow Report
31/10/23	PRICE SENSITIVE	376.8KB	Share
BDX Letter to Shareholders re Annual General Meeting Notice
20/10/23		201.99KB	Share
BDX Notice of Annual General Meeting/Proxy Form
20/10/23		783.67KB	Share
BDX Notification regarding unquoted securities - BDX
17/10/23		29.51KB	Share
BDX Cleansing Notice
17/10/23		189.53KB	Share
BDX Application for quotation of securities - BDX
17/10/23		25.31KB	Share
BDX AGM Date and Closing Date for Director Nominations
04/10/23		167.27KB	Share
BDX Annual Report to shareholders
29/09/23		2.55MB	Share
BDX Appendix 4G & Corporate Governance Statement
29/09/23		696.35KB	Share
BDX Directors Change of Interest Notice X 5
22/09/23		340.12KB	Share
BDX Cleansing Notice
19/09/23		190.43KB	Share
BDX Application for quotation of securities - BDX
18/09/23		27.23KB	Share
BDX Application for quotation of securities - BDX
18/09/23		24.75KB	Share
BDX BCAL Share Purchase Plan Closes
18/09/23		169.14KB	Share
BDX BCAL Locks Down Crucial Breast Cancer Signature
11/09/23		169.4KB	Share
BDX Change in substantial holding
05/09/23		255KB	Share
BDX Shane Ryan Appointed Chief Operating Officer
05/09/23		163.94KB	Share
BDX Cleansing Notice
01/09/23		189.56KB	Share
BDX Application for quotation of securities - BDX
01/09/23		24.83KB	Share
BDX Preliminary Final Report
30/08/23	PRICE SENSITIVE	505.25KB	Share
BDX Share Purchase Plan Offer Booklet
30/08/23	PRICE SENSITIVE	352.6KB	Share
BDX Proposed issue of securities - BDX
29/08/23		38.21KB	Share
BDX $2.4m Capital Raise to Further BREASTEST Commercialisation
28/08/23	PRICE SENSITIVE	169.6KB	Share
BDX BCAL Presentation August 2023
24/08/23		4.09MB	Share
BDX Trading Halt
24/08/23	PRICE SENSITIVE	254.54KB	Share
BDX Application for quotation of securities - BDX
11/08/23		24.85KB	Share
BDX Notification of cessation of securities - BDX
11/08/23		21.71KB	Share
BDX Application for quotation of securities - BDX
10/08/23		24.87KB	Share
BDX BCAL Investor Education Update & Webinar
08/08/23		3.61MB	Share
BDX Breakthrough Results a Major Step Towards Commercialisation
02/08/23	PRICE SENSITIVE	193.16KB	Share
BDX Application for quotation of securities - BDX
28/07/23		26.23KB	Share
BDX Shares and Options Released from Escrow
28/07/23		107.71KB	Share
BDX Quarterly Activities/Appendix 4C Cash Flow Report
27/07/23	PRICE SENSITIVE	387.47KB	Share
BDX Shareholder Newsletter
20/07/23		915.58KB	Share
BDX Notification regarding unquoted securities - BDX
30/06/23		28.08KB	Share
BDX Proposed issue of securities - BDX
30/06/23		25.57KB	Share
BDX BCAL Findings Presented at ASCO Annual Meeting
06/06/23		165.54KB	Share
BDX BCAL Appoints David Darling as Advisor
16/05/23		139.49KB	Share
BDX Notification regarding unquoted securities - BDX
11/05/23		24.59KB	Share
BDX Change of Director's Interest Notice
03/05/23		75.41KB	Share
BDX BCAL Opens Development & Clinical Service Laboratory
03/05/23		79.72KB	Share
BDX Quarterly Activities/Appendix 4C Cash Flow Report
24/04/23	PRICE SENSITIVE	219.05KB	Share
BDX Half Yearly Report and Accounts
23/02/23	PRICE SENSITIVE	557.69KB	Share
BDX Quarterly Activities/Appendix 4C Cash Flow Report
16/01/23	PRICE SENSITIVE	116.54KB	Share
BDX Results of Meeting
01/12/22		175.13KB	Share
BDX Results of Meeting
29/11/22		174.17KB	Share
BDX BCAL AGM Presentation
29/11/22		1.94MB	Share
BDX Shareholder Newsletter
16/11/22		2.67MB	Share
BDX Quarterly Activities/Appendix 4C Cash Flow Report
31/10/22	PRICE SENSITIVE	135.99KB	Share
BDX Letter to Shareholders on Annual General Meeting Notice
28/10/22		177.75KB	Share
BDX Notice of Annual General Meeting/Proxy Form
28/10/22		723.77KB	Share
BDX Establishment of Development & Clinical Service Laboratory
25/10/22		45.09KB	Share
BDX Appendix 4G and Corporate Governance Statement
29/09/22		272.35KB	Share
BDX Annual Report to shareholders
29/09/22		1.22MB	Share
BDX Preliminary Final Report
30/08/22	PRICE SENSITIVE	380.59KB	Share
BDX Application for quotation of securities - BDX
29/08/22		24.76KB	Share
BDX Proposed issue of securities - BDX
25/08/22		24.73KB	Share
BDX Quarterly Activities/Appendix 4C Cash Flow Report
28/07/22	PRICE SENSITIVE	111.26KB	Share
BDX Change of Director's Interest Notice
04/07/22		78.84KB	Share
BDX BCAL Enters US Product Development Agreement with Precion
28/06/22	PRICE SENSITIVE	50.05KB	Share
BDX Change in substantial holding
27/06/22		257.77KB	Share
BDX BCAL Presentation Accepted for 2022 ASCO Annual Meeting
01/06/22		38.53KB	Share
BDX Application for quotation of securities - BDX
03/05/22		24.88KB	Share
BDX BCAL to Present at NWR Virtual Investor Conference
02/05/22		37.7KB	Share
BDX Quarterly Activities/Appendix 4C Cash Flow Report
28/04/22	PRICE SENSITIVE	189.47KB	Share
BDX Shareholder Newsletter
24/03/22		326.25KB	Share
BDX Change of Director's Interest Notice
02/03/22		75.45KB	Share
BDX Appendix 4D & Interim Report
18/02/22	PRICE SENSITIVE	830.8KB	Share
BDX Shares to be released from escrow
14/02/22		45.35KB	Share
BDX 7 February Announcement - Additional Information
08/02/22	PRICE SENSITIVE	103.11KB	Share
BDX Recent Analysis Significantly Improves Commercial Prospects
07/02/22	PRICE SENSITIVE	48.81KB	Share

REFRESH

(20min delay)
Last 9.4¢		Change 0.001(1.08%)		Mkt cap ! $23.71M

Open	High	Low	Value	Volume
9.3¢	9.9¢	9.3¢	$4.177K	43.04K

Buyers (Bids)

No.	Vol.	Price($)
1	172	9.3¢

Sellers (Offers)

Price($)	Vol.	No.
10.5¢	95238	1

View Market Depth

No.	Vol.	Price($)
1	463678	0.091
3	221111	0.090
1	40000	0.087
1	500000	0.086
1	100000	0.085

Price($)	Vol.	No.
0.105	95238	1
0.110	90909	1
0.120	308139	2
0.130	136123	2
0.140	100000	1

Last trade - 12.45pm 10/05/2024 (20 minute delay)


Last 9.8¢		Change 0.001 ( 6.52 %)
Open	High	Low	Volume
9.1¢	9.8¢	9.1¢	36921
Last updated 11.55am 10/05/2024 ?

BDX (ASX) Chart

BCAL DIAGNOSTICS LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available